Tumor-infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple-negative invasive breast cancer.

Zhang, Lin; Wang, Xiaohong I; Zhang, Songlin

Zhang, Lin; Wang, Xiaohong I; Zhang, Songlin.

Afiliação

Zhang L; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030.
Wang XI; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030.
Zhang S; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030. Electronic address: Songlin.Zhang@uth.tmc.edu.

Hum Pathol ; 80: 47-54, 2018 10.

Article em En | MEDLINE | ID: mdl-29883779

Assuntos

Intervalo Livre de Doença; Linfócitos do Interstício Tumoral/patologia; Neoplasia Residual/patologia; Neoplasias de Mama Triplo Negativas/patologia; Adulto; Idoso; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Feminino; Humanos; Linfócitos/patologia; Linfócitos do Interstício Tumoral/imunologia; Pessoa de Meia-Idade; Terapia Neoadjuvante/métodos; Resultado do Tratamento

Palavras-chave

Neoadjuvant chemotherapy (NACT); Pathological complete response (pCR); Residual disease (RD); Triple-negative breast cancer (TNBC); Tumor-infiltrating lymphocyte volume (TILV); Tumor-infiltrating lymphocytes (TILs)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Neoplasia Residual / Intervalo Livre de Doença / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google